Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment

References

• ShiDBedfordNMChoHSEngineered multifunctional nanocarriers for cancer diagnosis and therapeuticsSmall20117182549256721648074
   PubMed Web of Science ®Google Scholar
• MahmoodiNOGhavidastAAmirmahaniNA comparative study on the nanoparticles for improved drug delivery systemsJ Photochem Photobiol B201616268169327498233
   PubMed Web of Science ®Google Scholar
• ChengZAlZAHuiJZMuzykantovVRTsourkasAMultifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilitiesScience2012338610990391023161990
   PubMed Web of Science ®Google Scholar
• GunatillakePAAdhikariRBiodegradable synthetic polymers for tissue engineeringEur Cell Mater20035116 discussion 1614562275
   PubMedGoogle Scholar
• AryalSHuCMZhangLPolymeric nanoparticles with precise ratio-metric control over drug loading for combination therapyMol Pharm2011841401140721696189
   PubMed Web of Science ®Google Scholar
• AcharyaSSahooSKPLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effectAdv Drug Deliv Rev201163317018320965219
   PubMed Web of Science ®Google Scholar
• GaoWHuCMFangRHZhangLLiposome-like nanostructures for drug deliveryJ Mater Chem B201314818
   Web of Science ®Google Scholar
• LukBTZhangLCell membrane-camouflaged nanoparticles for drug deliveryJ Control Release2015220pt B60060726210440
   PubMed Web of Science ®Google Scholar
• FangRHLukBTHuCMZhangLEngineered nanoparticles mimicking cell membranes for toxin neutralizationAdv Drug Deliv Rev201590698025868452
   PubMed Web of Science ®Google Scholar
• ZhangJGaoWFangRHDongAZhangLSynthesis of nanogels via cell membrane-templated polymerizationSmall201511344309431326044721
   PubMed Web of Science ®Google Scholar
• CoppJAFangRHLukBTClearance of pathological antibodies using biomimetic nanoparticlesProc Natl Acad Sci U S A201411137134811348625197051
   PubMed Web of Science ®Google Scholar
• WickiAWitzigmannDBalasubramanianVHuwylerJNanomedicine in cancer therapy: challenges, opportunities, and clinical applicationsJ Control Release201520013815725545217
   PubMed Web of Science ®Google Scholar
• FangRHKrollAVZhangLNanoparticle-based manipulation of antigen-presenting cells for cancer immunotherapySmall201511415483549626331993
   PubMed Web of Science ®Google Scholar
• VoonSHKiewLVLeeHBIn vivo studies of nanostructure-based photosensitizers for photodynamic cancer therapySmall201410244993501325164105
   PubMed Web of Science ®Google Scholar
• MinelliCLoweSBStevensMMEngineering nanocomposite materials for cancer therapySmall20106212336235720878632
   PubMed Web of Science ®Google Scholar
• HuCMZhangLAryalSCheungCFangRHZhangLErythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platformProc Natl Acad Sci U S A201110827109801098521690347
   PubMed Web of Science ®Google Scholar
• AryalSHuCMFangRHErythrocyte membrane-cloaked polymeric nanoparticles for controlled drug loading and releaseNanomedicine (Lond)2013881271128023409747
   PubMed Web of Science ®Google Scholar
• PiaoJGWangLGaoFYouYZXiongYYangLErythrocyte membrane is an alternative coating to polyethylene glycol for prolonging the circulation lifetime of gold nanocages for photothermal therapyACS Nano2014810104141042525286086
   PubMed Web of Science ®Google Scholar
• GuoYWangDSongQErythrocyte membrane-enveloped polymeric nanoparticles as nanovaccine for induction of antitumor immunity against melanomaACS Nano2015976918693326153897
   PubMed Web of Science ®Google Scholar
• FangRHHuCMZhangLNanoparticles disguised as red blood cells to evade the immune systemExpert Opin Biol Ther201212438538922332936
   PubMed Web of Science ®Google Scholar
• RaoLBuLLXuJHRed blood cell membrane as a biomimetic nanocoating for prolonged circulation time and reduced accelerated blood clearanceSmall201511466225623626488923
   PubMed Web of Science ®Google Scholar
• LukBTFangRHHuCMSafe and immunocompatible nanocarriers cloaked in RBC membranes for drug delivery to treat solid tumorsTheranostics2016671004101127217833
   PubMed Web of Science ®Google Scholar
• RaoLXuJHCaiBSynthetic nanoparticles camouflaged with biomimetic erythrocyte membranes for reduced reticuloendothelial system uptakeNanotechnology201627808510626820630
   PubMed Web of Science ®Google Scholar
• LukBTHuCMFangRHInterfacial interactions between natural RBC membranes and synthetic polymeric nanoparticlesNanoscale2014652730273724463706
   PubMed Web of Science ®Google Scholar
• TsaiRKRodriguezPLDischerDESelf inhibition of phagocytosis: the affinity of ‘marker of self’ CD47 for SIRPalpha dictates potency of inhibition but only at low expression levelsBlood Cells Mol Dis2010451677420299253
   PubMed Web of Science ®Google Scholar
• FangRHHuCMChenKNLipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticlesNanoscale20135198884888823907698
   PubMed Web of Science ®Google Scholar
• FuQLvPChenZProgrammed co-delivery of paclitaxel and doxorubicin boosted by camouflaging with erythrocyte membraneNanoscale2015794020403025653083
   PubMed Web of Science ®Google Scholar
• ZhouHFanZLemonsPKChengHA facile approach to functionalize cell membrane-coated nanoparticlesTheranostics2016671012102227217834
   PubMed Web of Science ®Google Scholar
• BellGIModels for the specific adhesion of cells to cellsScience19782004342618627347575
   PubMed Web of Science ®Google Scholar
• HuCMFangRHWangKCNanoparticle biointerfacing by platelet membrane cloakingNature2015526757111812126374997
   PubMed Web of Science ®Google Scholar
• DehainiDWeiXFangRHErythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalizationAdv Mater201729161606209
   Web of Science ®Google Scholar
• ParodiAQuattrocchiNvan de VenALSynthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functionsNat Nanotechnol201381616823241654
   PubMed Web of Science ®Google Scholar
• SunHSuJMengQCancer-cell-biomimetic nanoparticles for targeted therapy of homotypic tumorsAdv Mater201628439581958827628433
   PubMed Web of Science ®Google Scholar
• FangRHHuCMLukBTCancer cell membrane-coated nanoparticles for anticancer vaccination and drug deliveryNano Lett20141442181218824673373
   PubMed Web of Science ®Google Scholar
• RaoLBuLLCaiBCancer cell membrane-coated upconversion nanoprobes for highly specific tumor imagingAdv Mater201628183460346626970518
   PubMed Web of Science ®Google Scholar
• ZhuJYZhengDWZhangMKPreferential cancer cell self-recognition and tumor self-targeting by coating nanoparticles with homotypic cancer cell membranesNano Lett2016165895590127513184
   PubMed Web of Science ®Google Scholar
• SugaharaKNTeesaluTKarmaliPPTissue-penetrating delivery of compounds and nanoparticles into tumorsCancer Cell200916651052019962669
   PubMed Web of Science ®Google Scholar
• SugaharaKNTeesaluTKarmaliPPCoadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugsScience201032859811031103520378772
   PubMed Web of Science ®Google Scholar
• MantisCKandelaIAirdFReproducibility Project: Cancer Biology. Replication study: coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugsElife20176e1758428100395
   PubMed Web of Science ®Google Scholar
• TeesaluTSugaharaKNKotamrajuVRRuoslahtiEC-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetrationProc Natl Acad Sci U S A200910638161571616219805273
   PubMed Web of Science ®Google Scholar
• HaspelNZanuyDNussinovRTeesaluTRuoslahtiEAlemanCBinding of a C-end rule peptide to the neuropilin-1 receptor: a molecular modeling approachBiochemistry201150101755176221247217
   PubMed Web of Science ®Google Scholar
• ChenRBraunGBLuoXSugaharaKNTeesaluTRuoslahtiEApplication of a proapoptotic peptide to intratumorally spreading cancer therapyCancer Res20137341352136123248118
   PubMed Web of Science ®Google Scholar
• ZhangJWangLFaiCHCo-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cellsSci Rep201774605728470171
   PubMed Web of Science ®Google Scholar
• GaoFZhangJFuCiRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting abilityInt J Nanomedicine2017124147416228615942
   PubMed Web of Science ®Google Scholar
• HuangYLiXShaHsTRAIL-iRGD is a promising therapeutic agent for gastric cancer treatmentSci Rep20177157928373646
   PubMedGoogle Scholar
• ZhuZXieCLiuQThe effect of hydrophilic chain length and iRGD on drug delivery from poly(ε-caprolactone)-poly(N-vinylpyrrolidone) nanoparticlesBiomaterials201132359525953521903260
   PubMed Web of Science ®Google Scholar
• CeccarelliCPiazziGPateriniPConcurrent EGFr and Cox-2 expression in colorectal cancer: proliferation impact and tumour spreadingAnn Oncol200516suppl 4iv74iv7915923435
   PubMedGoogle Scholar
• ShaHLiRBianXA tumor-penetrating recombinant protein anti-EGFR-iRGD enhance efficacy of paclitaxel in 3D multicellular spheroids and gastric cancer in vivoEur J Pharm Sci201577607225998561
   PubMed Web of Science ®Google Scholar
• ShaHZouZXinKTumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapyJ Control Release201520018820025553823
   PubMed Web of Science ®Google Scholar
• WardESGüssowDGriffithsADJonesPTWinterGBinding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coliNature198934162425445462677748
   PubMed Web of Science ®Google Scholar
• TeillaudJLFrom whole monoclonal antibodies to single domain antibodies: think smallMethods Mol Biol201291131322886242
   PubMedGoogle Scholar
• MuyldermansSNanobodies: natural single-domain antibodiesAnnu Rev Biochem20138277579723495938
   PubMed Web of Science ®Google Scholar
• HarmsenMMDe HaardHJProperties, production, and applications of camelid single-domain antibody fragmentsAppl Microbiol Biotechnol2007771132217704915
   PubMed Web of Science ®Google Scholar
• BianXWuPShaHAnti-EGFR-iRGD recombinant protein conjugated silk fibroin nanoparticles for enhanced tumor targeting and antitumor efficiencyOnco Targets Ther201693153316227313461
   PubMed Web of Science ®Google Scholar
• XinXShaHShenJZhangBZhuBLiuBCoupling Gd-DTPA with a bispecific, recombinant protein anti-EGFR-iRGD complex improves tumor targeting in MRIOncol Rep20163563227323527035336
   PubMed Web of Science ®Google Scholar
• WangTWeiJQianXDingYYuLLiuBGambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cellsCancer Lett2008262221422218248784
   PubMed Web of Science ®Google Scholar
• WangLHLiYYangSNGambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signallingBr J Cancer2014110234135224300974
   PubMed Web of Science ®Google Scholar
• YinDYangYCaiHWangFPengDHeLGambogic acid-loaded electrosprayed particles for site-specific treatment of hepatocellular carcinomaMol Pharm201411114107411725290462
   PubMedGoogle Scholar
• WenCHuangLChenJGambogic acid inhibits growth, induces apoptosis, and overcomes drug resistance in human colorectal cancer cellsInt J Oncol20154751663167126397804
   PubMed Web of Science ®Google Scholar
• ZhangZQianHYangMGambogic acid-loaded biomimetic nanoparticles in colorectal cancer treatmentInt J Nanomedicine2017121593160528280328
   PubMed Web of Science ®Google Scholar
• ChouSHShettyAVGengYPalmitate-derivatized human IL-2: a potential anticancer immunotherapeutic of low systemic toxicityCancer Immunol Immunother201362359760323124508
   PubMed Web of Science ®Google Scholar
• KimSAPeacockJSThe use of palmitate-conjugated protein A for coating cells with artificial receptors which facilitate intercellular interactionsJ Immunol Methods1993158157658429217
   PubMed Web of Science ®Google Scholar
• HuangAHuangLKennelSJMonoclonal antibody covalently coupled with fatty acid. A reagent for in vitro liposome targetingJ Biol Chem198025517801580187410345
   PubMed Web of Science ®Google Scholar
• ChenAZhengGTykocinskiMLHierarchical costimulator thresholds for distinct immune responses: application of a novel two-step Fc fusion protein transfer methodJ Immunol2000164270571110623813
   PubMed Web of Science ®Google Scholar
• LiuSBreiterDRZhengGChenAEnhanced antitumor responses elicited by combinatorial protein transfer of chemotactic and costimulatory moleculesJ Immunol200717853301330617312181
   PubMed Web of Science ®Google Scholar
• ZhengGChenASternerREInduction of antitumor immunity via intratumoral tetra-costimulator protein transferCancer Res200161228127813411719441
   PubMed Web of Science ®Google Scholar
• LiuSFosterBAChenTZhengGChenAModifying dendritic cells via protein transfer for antitumor therapeuticsClin Cancer Res200713128329117200367
   PubMed Web of Science ®Google Scholar
• ChenAZhengGTykocinskiMLQuantitative interplay between activating and pro-apoptotic signals dictates T cell responsesCell Immunol2003221212813712747954
   PubMed Web of Science ®Google Scholar
• ZhuJTangCKottke-MarchantKMarchantREDesign and synthesis of biomimetic hydrogel scaffolds with controlled organization of cyclic RGD peptidesBioconjug Chem200920233333919191566
   PubMed Web of Science ®Google Scholar